EW Healthcare Partners

Manufacturer of integrated electronic product design and contract manufacturing services to the medical, industrial, and defense segments. The company provides efficient and controlled production via automation, robotics, and software systems that control and trace materials and processes throughout the factory.

VitalConnect specializes in wearable biosensor technology aimed at enhancing patient monitoring both in hospitals and remotely. The company utilizes its expertise in biomedical engineering, data analytics, and chip design to develop products that continuously monitor vital signs through an adhesive patch. These innovations include the Vista Solution, which provides healthcare professionals with 24/7 access to patient health data via an online portal, tracking 11 vital signs and offering predictive analytics. The VitalPatch biosensor specifically measures critical parameters such as EKG, heart rate, respiratory rate, and body temperature, facilitating immediate responses to urgent health situations. By combining these technologies, VitalConnect's solutions improve patient mobility and comfort while enabling clinicians to optimize treatment through comprehensive patient insights, ultimately leading to better health outcomes and reduced economic burdens.

Laboratoires Majorelle is a French independent pharmaceutical company focused on addressing public health concerns, particularly in the field of sexual health. Established with the goal of improving access to essential medicines, the company specializes in offering contraception and treatments for sexually transmitted diseases, erectile disorders, and urinary incontinence. By prioritizing responsible practices, Laboratoires Majorelle aims to provide effective health solutions for both men and women in France, ensuring that critical health needs are met.

COTA, Inc. is a Boston-based company that specializes in developing a platform designed to provide data and insights related to cancer patients, aimed at guiding treatment decisions. Founded in 2011 by a team of doctors, engineers, and data scientists, COTA utilizes proprietary technology and advanced analytics to transform fragmented electronic health record (EHR) data into cohesive, research-grade information. This platform supports oncology practices and cancer centers by identifying variations in care, thus enabling the design of effective treatment programs and payment models. COTA's solutions serve a diverse range of stakeholders, including healthcare providers, payers, life sciences companies, and the FDA, ultimately striving to enhance patient outcomes and reduce healthcare costs associated with cancer care.

Metabolon is a technology company, develops analytical methods and software for biomarker discovery using metabolomics. It offers a biochemical profiling platform that analyzes and identifies biochemicals in the research of pharmaceutical, biotech, agriculture, cosmetic, and consumer products. Metabolon provides a unique, real-time fingerprint of biological system to reveal novel discoveries and realize the promise of precision medicine. The company can deliver an instantaneous snapshot of the entire physiology of a living being at a discreet point in time, as well as identify changes in that system brought about the impact of the disease, medical intervention, diet, or the environment. This deep and comprehensive view of the metabolome provides biological insights that cannot be revealed through any other research methodology, enabling life sciences researchers and drug developers to discover answers to some of biology’s most difficult questions. Metabolon was founded in 2000 and headquartered in Durham, North Carolina.

MiMedx Group, Inc. is a biopharmaceutical company that specializes in developing and marketing regenerative biologics using human placental tissue allografts. The company employs a proprietary processing method known as the PURION Process, which utilizes aseptic techniques and terminal sterilization to create its allografts. MiMedx offers a range of biomaterial technologies, including EpiFix and AmnioFix, which are utilized in treating chronic wounds and surgical procedures, respectively. Other notable products include EpiCord and AmnioCord, which serve as connective tissue matrices, and AmnioFill, designed to enhance healing. The company's offerings cater to various medical fields, including wound care, orthopedics, sports medicine, ophthalmology, and dentistry. MiMedx sells its products through a combination of direct sales, independent agents, and distributors in the United States and internationally. Headquartered in Marietta, Georgia, MiMedx Group has been operational since February 2008.

Cognate Bioservices is a fully-integrated contract bioservices organization providing the highest level of scientific and management expertise. Cognate provides full development and cGMP manufacturing services to companies and institutions engaged in the development of cell-based products. The combination of highly experienced staff, successful track records and cGMP facilities makes Cognate one of the most qualified contract manufacturers of cell-based products in the world today.

Sonendo, Inc. is a medical technology company that focuses on advancing dental care through innovative devices for root canal therapy. Based in Laguna Hills, California, Sonendo has developed the GentleWave® System, which enhances the cleaning and disinfection of tooth canals, improving clinical outcomes and efficiency compared to traditional methods. The company operates primarily through two segments: the Product segment, which includes sales of the GentleWave System and its related instruments, and the Software segment, which encompasses TDO® Software—widely recognized as a leading practice management solution for endodontics. Since its incorporation in 2006, Sonendo has aimed to transform dentistry by promoting effective treatments that preserve tooth structure and enhance patient care.

Venus Concept Inc. is a medical aesthetic technology company based in Toronto, Canada, specializing in innovative solutions for aesthetic treatments. Founded in 2009, the company offers a diverse range of products, including Venus Versa, a multi-treatment platform for non-surgical procedures; Venus Legacy, designed for skin tightening and body contouring; and Venus Viva, a customizable skin resurfacing device. Additionally, Venus Concept provides Venus Freeze Plus for anti-aging and non-invasive skin tightening, and Venus Bliss for fat reduction. The company also features advanced hair restoration technologies, including NeoGraft and ARTAS robotic systems, which streamline the follicle harvesting process. Committed to ethical practices and technological advancement, Venus Concept aims to enhance the patient experience in the medical aesthetics industry.

Cognate Bioservices is a fully-integrated contract bioservices organization providing the highest level of scientific and management expertise. Cognate provides full development and cGMP manufacturing services to companies and institutions engaged in the development of cell-based products. The combination of highly experienced staff, successful track records and cGMP facilities makes Cognate one of the most qualified contract manufacturers of cell-based products in the world today.

Encore Dermatology is a privately held fully-integrated dermatology company that provides prescription therapies and medical devices to dermatologists. It provides a range of medical dermatology products, treating a number of topical disease states that enable patients to get improved skin care and treatment with ease. Encore Dermatology was established in 2015 and is headquartered in Malvern, Pennsylvania.

EyePoint Pharmaceuticals is a specialty biopharmaceutical company focused on developing and commercializing ophthalmic products for the treatment of eye diseases, primarily in the United States and Europe. The company offers several FDA-approved products, including ILUVIEN for diabetic macular edema, YUTIQ for chronic non-infectious uveitis, DEXYCU for post-operative ocular inflammation, and Retisert for posterior segment uveitis. EyePoint is also advancing its pipeline with EYP-1901, a bioerodible implant targeting wet age-related macular degeneration and related conditions, as well as YUTIQ50 for uveitis. The company utilizes its proprietary Durasert and Verisome technology platforms to create sustained-release drug delivery systems. EyePoint has established strategic collaborations with various organizations and engages in a commercial alliance for the promotion of its products. Founded in 1987 and headquartered in Watertown, Massachusetts, EyePoint was previously known as pSivida Corp.

COTA, Inc. is a Boston-based company that specializes in developing a platform designed to provide data and insights related to cancer patients, aimed at guiding treatment decisions. Founded in 2011 by a team of doctors, engineers, and data scientists, COTA utilizes proprietary technology and advanced analytics to transform fragmented electronic health record (EHR) data into cohesive, research-grade information. This platform supports oncology practices and cancer centers by identifying variations in care, thus enabling the design of effective treatment programs and payment models. COTA's solutions serve a diverse range of stakeholders, including healthcare providers, payers, life sciences companies, and the FDA, ultimately striving to enhance patient outcomes and reduce healthcare costs associated with cancer care.

Venus Concept Inc. is a medical aesthetic technology company based in Toronto, Canada, specializing in innovative solutions for aesthetic treatments. Founded in 2009, the company offers a diverse range of products, including Venus Versa, a multi-treatment platform for non-surgical procedures; Venus Legacy, designed for skin tightening and body contouring; and Venus Viva, a customizable skin resurfacing device. Additionally, Venus Concept provides Venus Freeze Plus for anti-aging and non-invasive skin tightening, and Venus Bliss for fat reduction. The company also features advanced hair restoration technologies, including NeoGraft and ARTAS robotic systems, which streamline the follicle harvesting process. Committed to ethical practices and technological advancement, Venus Concept aims to enhance the patient experience in the medical aesthetics industry.

Abiomed is a company that specializes in mechanical circulatory support devices, aimed at aiding heart failure patients. The firm develops, manufactures, and markets products designed to enable the heart to rest, heal, and recover by enhancing blood flow or temporarily assisting its pumping function. Its devices are utilized in cardiac catheterization labs by interventional cardiologists and in surgical settings by heart surgeons for patients requiring hemodynamic support before, during, or after angioplasty and heart surgery. The majority of Abiomed's revenue comes from its Impella product portfolio, which includes advanced percutaneous micro heart pumps equipped with integration motors and sensors, as well as catheter-based systems.

Breg, Inc. is a manufacturer and marketer of sports medicine products and services focused on orthopedic patient care. The company offers a diverse array of products, including knee braces, cold therapy devices, various bracing solutions for the upper and lower extremities, and specialized items for conditions such as deep vein thrombosis. Breg also provides workflow management software known as Breg Vision, enhancing the efficiency of healthcare practices. Founded in 1989 and headquartered in Carlsbad, California, Breg operates through a network of distributors both in the United States and internationally. Its commitment to providing affordable healthcare solutions has established it as a significant player in the orthopedic product market.

Provider of contact center-based communication services intended to connect patients to small practices, large medical groups, and other healthcare providers. The company offers automatic answering services, appointment reminders, call management, appointment scheduling, confidential messaging, and other related services, enabling clients to improve patient retention and engage patients without burdening physician office staff.